FUJIFILM Diosynth Biotechnologies expanding College Station facility

Published: Dec. 14, 2021 at 7:18 AM CST
Email This Link
Share on Pinterest
Share on LinkedIn

COLLEGE STATION, Texas (KBTX) - FUJIFILM Diosynth Biotechnologies is investing even more in the BCS area. The company announced plans Tuesday morning to expand the production facility, doubling the company’s advanced therapy and vaccine manufacturing capacity in the U.S.

The $300 million new facility is expected to be up and running by 2024 and will add about 130,000 square feet to its current location.

“As the need for advanced therapies development and manufacturing capacity grows, we will continue to invest in the right technology and talent to support our partners in bringing to market these life-impacting medicines,” said Gerry Farrell, chief operating officer of FUJIFILM Diosynth Biotechnologies, in a statement. “We are grateful to Governor Greg Abbott, and the State of Texas for its commitment to supporting the growth of the Texas biocorridor, and creating highly-skilled jobs in the state. We are also grateful to the cities of Bryan and College Station and Brazos County for their continued support with this initiative.”

“FUJIFILM Diosynth Biotechnologies’ expansion is wonderful news for the hardworking people of College Station-Bryan, and it will bring more opportunities for Texans to develop life-saving technology and treatment,” said Governor Greg Abbott in a statement. “The biotechnology industry is growing at a tremendous rate in Texas, and I thank FUJIFILM Diosynth Biotechnologies for their continued investment in the Brazos Valley that will keep the Lone Star State competitive in this field.”

FujiFilm Diosynth Biotechnologies says they will add 150 skilled positions by 2024.

The company says it will expand their reach in the industry of Contract Development and Manufacturing Organization.

“This investment will expand our advanced therapies in vaccine manufacturing capacity and will make our Texas site the largest single use CDMO campus in North America. It also builds on a $120 million investment we announced in November of 2019 which is in the final stages of completion,” said Gerry Farrell, Ph.D., FujiFilm Diosynth Biotechnologies Chef Operating Officer.

These ew jobs are being supported by Governor Greg Abbott through a $1.5 million Enterprise Fund Award.

“What the governor did was he said, you heard there’s 150 jobs and the Governor’s Enterprise Fund committed $10,000 per job that’s created with this new building, so that’s an added incentive for Fuji to come here,” explained Mayor Karl Mooney of College Station.

Mooney tells us the announcement puts our Biocorridor even more on the map.

“Austin might be the technology capital for the State of Texas but even the Governor’s office will tell you Bryan - College Station has become the Biocorridor for the State of Texas,” he said.

Matt Prochaska with the Brazos Valley Economic Development Corporation tells us the new jobs will average around $80,000 in salary.

“This is definitely the result of a lot of years of work, relationship buildings and really just wonderful team work all the way from the university and the system to our governor and then all of our local entities,” said Prochaska.

The facility is expected to be operational by 2024. The expansion will double the company’s advanced therapy and vaccine manufacturing capacity in the United States.

Copyright 2021 KBTX. All rights reserved.